Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
330.64
+0.13 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
40
41
Next >
Amgen Options Trading: A Deep Dive into Market Sentiment
January 30, 2024
Via
Benzinga
Expert Outlook: Amgen Through The Eyes Of 11 Analysts
January 29, 2024
Via
Benzinga
Is Amgen a Good Dividend Stock to Buy Right Now?
January 29, 2024
Its diverse product mix and strong fundamentals make a decent case.
Via
The Motley Fool
Amgen's Planning to Take a Bite Out of Cancer. Here's What It Means for the Stock.
January 27, 2024
Its new approach to treating cancer is more than just a nibble around the edges.
Via
The Motley Fool
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
The popular dividend-investing strategy has been around for years. Is it right for you?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
P/E Ratio Insights for Amgen
January 26, 2024
Via
Benzinga
ABBV: This Top Biotech Just Went On A Buying Spree
January 25, 2024
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
Via
Talk Markets
Amgen Options Trading: A Deep Dive into Market Sentiment
January 17, 2024
Via
Benzinga
Why NASDAQ:AMGN is a Top Pick for Dividend Investors.
January 12, 2024
Balancing Dividends and Fundamentals: The Case of AMGEN INC (NASDAQ:AMGN).
Via
Chartmill
How Is The Market Feeling About Amgen?
January 10, 2024
Via
Benzinga
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
January 25, 2024
The best weight-loss drug stocks firms improving the drugs or developing new, potentially superior weight-loss treatments.
Via
InvestorPlace
What's Going On Johnson & Johnson Stock Today?
January 24, 2024
JNJ reports strong earnings, beats expectations for Q4 of 2023, with increased sales and successful acquisitions. Stock closes lower, settles talc litigation, and delays competitor's launch.
Via
Benzinga
Topics
Earnings
Exposures
Financial
This 1 Bullish Move by Merck Could Drive Growth for Years to Come
January 23, 2024
It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.
Via
The Motley Fool
5 Magnificent Dividend Growth Stocks to Buy and Hold Forever
January 23, 2024
These dividend growers ought to shine in 2024 and beyond.
Via
The Motley Fool
Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning
January 19, 2024
FDA issues serious warning on Amgen's Prolia drug, highlighting increased risk of low calcium levels in specific patient groups.
Via
Benzinga
Exposures
Product Safety
Looking At Amgen's Recent Unusual Options Activity
January 09, 2024
Via
Benzinga
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors
January 08, 2024
Via
Benzinga
Dividend Income Update December 2023
January 17, 2024
The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated.
Via
Talk Markets
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
January 16, 2024
On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units.
Via
Benzinga
Topics
ETFs
Stocks Struggle As U.S. Dollar Sees Safety Bid
January 16, 2024
Once again, we are seeing stocks struggle whenever the dollar catches a bid. But not all hope is lost for bulls, as various semiconductor stocks continue to hold up well.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
These five biotech companies could have a lot of room to run.
Via
The Motley Fool
Why Vera Therapeutics Stock Soared by 22% This Week
January 12, 2024
Executive changes and a bullish analyst take combined to boost sentiment on the company.
Via
The Motley Fool
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the
Via
Benzinga
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains
January 11, 2024
AbbVie Inc (ABBV) stock is up 15% since acquiring ImmunoGen, but past Golden Cross rallies haven't sustained. With high valuation and competition, investors may want to wait for a pullback.
Via
Benzinga
Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains
January 10, 2024
Buying Dogs of the Dow stocks is an attractive strategy that involves buying stocks with high dividend yields that have often underperformed.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
January 10, 2024
Cramer shared his insights during his attendance at JPMorgan's healthcare conference,
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
January 08, 2024
Via
Benzinga
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.
Via
Benzinga
A Rough Start To 2024 What Might Be In Store For The Rest Of 2024?
January 07, 2024
The market was weighed down by several negative factors that began before the bell even rang at Broad and Wall on the first trading day of this New Year.
Via
Talk Markets
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.